Select Page

Maria Stamelou

Visiting Associate Professor, Neurology

[email protected]

22559410

School of Medicine

Visiting Professor

Academic Qualifications

Qualification Year Awarding Institution Department
Apl. Professor 2017 Philipps University, Marburg, Germany Neurology
Assistant Professor (Privat Dozent) 2014-2017 Philipps University, Marburg, Germany Neurology
PhD 2009 Philipps University, Marburg, Germany Neurology
MD 2002 Aristoteleio Panepistimio Thessalonikis, Greece Medicine

Employment History

Period of employment Employer Location Position
From To
2012 2018 Philipps University Marburg, Germany Apl. Professor
2010 2012 University College London London, UK Research Fellow and honorary clinical assistant
2005 2010 Philipps University Philipps University PhD Student and Neurology registrar

Publications

Year Title Other authors Journal and Publisher / Conference Vol. Pages
2019 Stamelou M. Neuroprotection in multiple system atrophy: unresolved issues. - Lancet Neurol. Aug;18(8) 710-711
2019 One decade ago, one decade ahead in progressive supranuclear palsy. Giagkou N, Höglinger GU Mov Disord Sep;34 (9) 1284-1293
2019 Motor function and the probability of prodromal Parkinson's disease in older adults... Maraki MI, Stefanis L, Yannakoulia M, Kosmidis MH, Xiromerisiou G, Dardiotis E, Hadjigeorgiou GM, Sakka P, Scarmeas N, Mov Disord Sep; 34(9) 1345-1353
2019 Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy.: - Mov Disord. 2019 Aug;34 (8) 1087-1088
2019 Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M. Lancet Neurol. Aug;18 (8) 748-759
2018 Selective cognitive impairment and hyposmia in p.A53T SNCA PD vs typical PD Koros C,* Stamelou M,* Simitsi A, Beratis I, Papadimitriou D, Papagiannakis N, Fragkiadaki S, Kontaxopoulou D, Papageorgiou SG, Stefanis L. Neurology Mar 6;90(10) e864-e869
2017 ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients Carecchio M, Mencacci NE, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M*, Nardocci N*. Parkinsonism Relat Disord Aug;41 37-43
2017 Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Höglinger GU, Respondek G, Stamelou M, et al; Movement Disorder Society-endorsed PSP Study Group. Mov Disord Jun;32 (6) 853-864
2017 Which ante mortem clinical features predict progressive supranuclear palsy pathology? Respondek G, Kurz C, Arzberger T, Compta Y,.., Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group. Mov Disord Jul;32(7) 995-1005
2016 Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Stamelou M, Schöpe J, Wagenpfeil S, Del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer A, Höglinger GU; AL-108-231 Investigators, Tauros Investigators, and MDS-Endorsed PSP Study Group. Mov Disord May;31(5) 742-7

Exhibitions

Research Projects

Date Title Funded by Project Role*
2018-2020 A double-blind, placebo-controlled trial of a tau monoclonal antibody for PSP (Biogen) Biogen Principal Investigator
2019- A double-blind, placebo-controlled trial of GZ/SAR402671 for GBA Parkinson’s disease (SANOFI) Sanofi Principal Investigator
Since 2015 The Parkinson's Progression Markers Initiative (PPMI) the Michael J Fox Foundation Co-Principal Investigator and coordinator
2005-2010 At least 12 clinical trials in Parkinson’s disease and PSP as evidenced in the relevant publications Several companies Sub-investigator

Academic Consulting Services/Councils/Boards/Editorial Committees

Period Organization Title of Position or Service Key Activities
Since 2015 International Parkinson’s disease and Movement Disorders Society (MDS) Assistant Editor to the society’s journal, the Movement Disorders Journal Editorial meeting with Editor in Chief and Debuty Editor twice a week, to discuss papers and make decisions.

Awards/International Recognition

Date Title Awarded by:
  2019 Greek L’Oreal-UNESCO For Women in Science Award UNESCO and L’oreal
Since 2015 Fellow of the European Academy of Neurology’ (FEAN) European Academy of Neurology
2015 Leadership training programme, LEAP – International Parkinson’s disease and Movement Disorders society (MDS) International Parkinson’s disease and Movement Disorders Society
2012 EFNS Scientific Fellowship from the European Federation of Neurological Societies for post-doctoral European Federation of Neurological Societies (later became the EAN)
2010 Award for “Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial”, Germany Freundlich – Stiftung
2009 Dissertation award for the best PhD in human medicine in Germany MLP
2009 For the best PhD in human medicine in 2009 Philipps University Marburg, Germany
2005 Fellowship from the (Greek) Hellenic Neurological Society (ENEE) to conduct PhD at Philipps - University Marburg, Germany (Greek) Hellenic Neurological Society (ENE)
2002 Grant from the Greek State Scholarships Foundation (IKY) as an exchange student in University of Freiburg, Germany Greek State Scholarships Foundation (IKY)

Other Achievements